FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2024
Back to search
Official data from USPTO
TWINPIGBIOLAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
02/05/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
12/29/2021
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
10/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
PERKINS, ELLEN J
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "TWINPIGBIOLAB" where the term "TWINPIG" appears in green and the term "BIOLAB" appears in blue.
Holders and representatives
Holders
TWINPIGBIOLAB INC.
Representatives
Leigh Ann Lindquist Sughrue Mion, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; diagnostic agents for medical purposes; drug delivery agents in the form of dissolvable filmscoating for tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for cancer treatment; medicines for human purposes for cancer treatment; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; pharmaceutical diagnostic preparations for medical purposes; ethical medicinal preparations for cancer treatment; pharmaceuticals for the treatment of cancer; non-prescription medicines for intestinal disorders and for the treatment of cardiovascular diseases; biological preparations for the treatment of cancer; pharmaceutical compounds for treating cancer
Class 42
Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to scientific research in the field of pharmacogenetics; providing medical research information and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; medical laboratory services; consultancy in laboratory analysis of biology sequence processing for medical research purposes; medical research laboratory services; medical research; analysis and evaluation of medical product developmentnamely new product testing and design; providing information on the testingquality evaluation and research of medical products; consultancy in the field of testingquality evaluationresearch of medical products; scientific research in the fields of medicinecancerous diseases and pharmacology; research and development of technology for biotechnology; scientific research in the fields of biomedicine; scientific research of biologics
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/18/2024
FIMP
FINAL DISPOSITION PROCESSED
01/18/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/16/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2023
PUBO
PUBLISHED FOR OPPOSITION
08/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/26/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/12/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/12/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/12/2023
RFNT
REFUSAL PROCESSED BY IB
01/09/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/17/2022
RFRR
REFUSAL PROCESSED BY MPU
12/17/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/07/2022
CNRT
NON-FINAL ACTION WRITTEN
10/06/2022
DOCK
ASSIGNED TO EXAMINER
09/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/10/2022
Continuous trademark protection
Get notified about every new filing that threatens TWINPIGBIOLAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.